SCHEMBL2178491

SCHEMBL2178491

CCN1CCOc2c1c(NCC1CCN(C)CC1)nn1c(-c3ccc(O)cc3)nnc21

nearest known ligand 0.84

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 11/20 0.84
PIM2 Q9P1W9 7/20 0.61
PIM3 Q86V86 4/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2176614 0.91 PIM1 (1.00) PIM1PIM2PIM3
SCHEMBL2176300 0.82 PIM1 (1.00) PIM1PIM2PIM3
SCHEMBL14762139 0.81 PIM2 (0.91) PIM1PIM2PIM3
SCHEMBL2179124 0.81 PIM1 (1.00) PIM1PIM2PIM3
SCHEMBL12494539 0.78 PIM1 (0.91) PIM1PIM2PIM3
SCHEMBL14762210 0.76 PIM2 (1.00) PIM1PIM2PIM3
SCHEMBL12496028 0.76 PIM1 (1.00) PIM1PIM2PIM3
SCHEMBL12497724 0.75 PIM1 (1.00) PIM1PIM2PIM3
SCHEMBL2179053 0.75 PIM3 (1.00) PIM1PIM2PIM3
SCHEMBL15602920 0.74 PIM1 (0.83) PIM1PIM2PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519526-A1 TRICYCLIC COMPOUNDS FOR USE AS KINASE INHIBITORS Centro Nacional de Investigaciones Oncológicas (CNIO) (ES) 2012-11-07 EP disclosed
WO-2011080510-A1 TRICYCLIC COMPOUNDS FOR USE AS KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2011-07-07 WO disclosed